Results 151 to 160 of about 68,243 (289)

Neuronal differentiation and tissue engineering strategies for central neurous system injury repair

BMEMat, EarlyView.
This review outlines tissue engineering advances for central nervous system (CNS) injury treatment, focusing on three core components: seed cells, inductive factors, and scaffold materials, with evaluation of their respective strengths and limitations. Tissue engineering for CNS injury repair.
Zhuqing Xia, Jinghui Zhang, Na Ren, Shuping Wang, Congcong Zhang, Nik Ahmad Nizam Nik Malek, Wan Hairul Anuar Kamaruddin, Chao Liu, Chunhui Sun, Jingang Wang   +9 more
wiley   +1 more source

Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device

Journal of Chest Surgery
Background: Left ventricular assist devices (LVADs) are widely employed as a therapeutic option for end-stage heart failure. We evaluated the outcomes associated with centrifugal- flow LVAD implantation, comparing 2 device models: the Heartmate 3 (HM3)
Kinam Shin, Won Chul Cho, Nara Shin, Hong Rae Kim, Min-Seok Kim, Cheol Hyun Chung, Sung-Ho Jung   +6 more
doaj   +1 more source

Routine Postoperative Cardiac Monitoring with Hemodynamic Transesophageal Echocardiography (hTEE) for Patients with Left Ventricular Assist Device (LVAD) [PDF]

, 2016
Nataliya Bahatyrevich, Qian Yang, Hitoshi Hirose, Nicholas C. Cavarocchi   +3 more
openalex   +1 more source

Right Ventricular Global Longitudinal Strain as a Predictor of Acute and Early Right Heart Failure Post Left Ventricular Assist Device Implantation

, 2021
Lusha W Liang, Alisha Jamil, Jeremy A Mazurek, Kimberly A Urgo, Joyce Wald, Edo Y. Birati, Yuchi Han, Lusha W Liang   +7 more
openalex   +2 more sources

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

Hospice Referral Patterns for Patients with Left Ventricular Assist Devices (LVAD) (S734) [PDF]

, 2017
Laura Dingfield, James N. Kirkpatrick, Nina O’Connor   +2 more
openalex   +1 more source

Bereaved Caregiver Perspectives on Implantation and End of Life in Pediatric Ventricular Assist Device Patients

, 2022
Christine M. Bui, Lauren Schneider, Monique J. Brown, Colleen K. McIlvennan, Danton Char, Seth A. Hollander   +5 more
openalex   +1 more source

Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Patients with hypertrophic obstructive cardiomyopathy (HOCM) were excluded from all major trials for transcatheter aortic valve replacement (TAVR). “Suicide left ventricle” occurring after TAVR is postulated to occur as a result of chronic pressure overload from fixed obstruction that is acutely relieved after the valve deployment ...
Muhammad Usman Almani, Vibhor Ahluwalia, Muhammad Yousuf, Jafar Alzubi, Mohammad Hamza, Raphael Bonita, Christian Witzke   +6 more
wiley   +1 more source

Transfemoral Transcatheter Aortic Valve Implantation (TF‐TAVI) for Patients With Left Ventricular Assist Device (LVAD) and Aortic Regurgitation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Aortic regurgitation (AR) develops in up to 25%−30% of patients with left ventricular assist device (LVAD). Treatment remains challenging since surgery confers significant peri‐operative risk and the lack of valvular calcification renders transfemoral transcatheter aortic valve implantation (TF‐TAVI) with non‐dedicated devices technically ...
Daniel Tai‐Leung Chan, Ho‐On Alston Conrad Chiu, Ka‐Lam Wong, Ka‐Chun Un, Kwong‐Yue Eric Chan, Shu‐Yue Sze, Chor‐Cheung Frankie Tam, On‐Yat Wong, Gilbert H. L. Tang, Simon Cheung‐Chi Lam   +9 more
wiley   +1 more source

Surgical Correction of Left Ventricular Assist Device Outflow Graft Obstruction Caused by a Wrapped Expanded Polytetrafluoroethylene Graft: A Case Report

Journal of Chest Surgery
A 70-year-old man with dilated cardiomyopathy underwent left ventricular assist device (LVAD) implantation, using a HeartWare ventricular assist device, as a bridge to candidacy.
Sung Min Kim, Ilkun Park, Siwon Oh, Hyo Won Seo, Ga Hee Jeong, Jun Ho Lee, Su Ryeun Chung, Kiick Sung, Wook Sung Kim, Yang Hyun Cho   +9 more
doaj   +1 more source